BrachytherapyRadiation InjuriesRadiotherapy, ConformalDose-Response Relationship, RadiationRadiotherapyRadiotherapy DosageProstatic NeoplasmsDose FractionationUltraviolet RaysRadiation DosageCombined Modality TherapyNuclear EnergyRadiotherapy, Intensity-ModulatedProstate-Specific AntigenRadiotherapy, AdjuvantRectumRadiation MonitoringRectal DiseasesTreatment OutcomeAndrogen AntagonistsNeoplasm Recurrence, LocalProstatectomyNeoplasmsNeoplasms, Radiation-InducedNuclear ReactorsRetrospective StudiesRadiation, IonizingRadiotherapy Planning, Computer-AssistedDisease-Free SurvivalFollow-Up StudiesRadiometryNeoplasm StagingRadiation ToleranceSurvival RateSurvival AnalysisNuclear WarfareRadiation OncologyRadioactive FalloutCarcinogensPrognosisAir Pollution, RadioactiveRadiationRadiotherapy, High-EnergyKazakhstanTime FactorsAdenocarcinomaRadiation ProtectionThyroid NeoplasmsRadioisotopesBrain NeoplasmsAneuploidyRadiosurgeryRadiation PneumonitisRadiotherapy, Computer-AssistedCell Transformation, NeoplasticTomography, X-Ray ComputedRadiotherapy, Image-GuidedRadiation-Sensitizing AgentsCarcinomaParticle AcceleratorsIodine RadioisotopesRisk AssessmentRadiation Injuries, ExperimentalOrgans at RiskHead and Neck NeoplasmsCranial IrradiationGamma RaysChemotherapy, AdjuvantRisk FactorsCarcinoma, Squamous CellChemoradiotherapyCosmic RadiationBreast NeoplasmsMagnetic Resonance ImagingAntineoplastic Combined Chemotherapy ProtocolsRadiodermatitisRadiobiologyOccupational ExposureCobalt RadioisotopesIridium RadioisotopesRadiation-Protective AgentsMastectomy, SegmentalLung NeoplasmsBackground RadiationKaplan-Meier EstimateCone-Beam Computed TomographyTumor BurdenUterine Cervical NeoplasmsCisplatinRectal NeoplasmsNeoplasms, Second PrimaryAntineoplastic AgentsPhantoms, ImagingFluorouracilX-RaysFiducial MarkersPhotonsRadiation EffectsRadioisotope TeletherapyFour-Dimensional Computed Tomography